Share: Facebook Twitter LinkedIn
Activity Provided By:

Physicians’ Education Resource®, LLC

Expert Illustrations & Commentaries: Visualizing Therapies on the Horizon for Presbyopia

Access Activity

Overview / Abstract:

Target Audience
This educational activity is directed toward ophthalmologists and optometrists, including those in residency and fellowship training. Other clinicians involved in the care of patients suffering from presbyopia are also invited to participate.

Program Overview
This Expert Illustrations and Commentaries™ is a video-based program in which 2 experts discuss the etiology and management of presbyopia. In this activity, the faculty focus on the pathophysiology and current and emerging therapeutic strategies for the management of presbyopia. Their discussion is enriched with the use of video animation to illustrate the pathophysiology of presbyopia and the mechanism of action of a new therapies. The use of these animated segments helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians identify best practices in the diagnosis and management of presbyopia and to improve outcomes for their patients with this disease.

An estimated 110 million people in the United States have presbyopia. It is the most common visual impairment of the “baby boomer” generation (born between 1946 and 1964). Despite the prevalence of presbyopia, even in developed countries, around one-third of presbyopia remains untreated. If left uncorrected, presbyopia can affect both quality of vision and quality of life. Presbyopia can inhibit a person’s ability to perform tasks at a customary working distance without experiencing visual symptoms, even if those tasks were once performed effortlessly. If presbyopia is going to occur, it typically begins after age 40 and is progressive until around 65 years, when near focusing can be completely lost.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:

Discuss the pathophysiology of presbyopia as related to loss of accommodation
Summarize current approaches to the treatment of presbyopia
Describe the mechanisms of action for novel topical therapies for presbyopia
Evaluate the efficacy and safety of emerging, investigational topical therapies for presbyopia

Expiration

Sep 17, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

1.0

Accreditation

ACCME

Presenters / Authors / Faculty

Francis S. Mah, MD
Selina R. McGee, OD, FAAO

Sponsors / Supporters / Grant Providers

AbbVie

Keywords / Search Terms

Relias LLC Relias, Free CME, Presbyopia Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map